CH455775A - Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten - Google Patents

Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten

Info

Publication number
CH455775A
CH455775A CH754964A CH754964A CH455775A CH 455775 A CH455775 A CH 455775A CH 754964 A CH754964 A CH 754964A CH 754964 A CH754964 A CH 754964A CH 455775 A CH455775 A CH 455775A
Authority
CH
Switzerland
Prior art keywords
preparation
acetic acid
acid derivatives
indolyl acetic
indolyl
Prior art date
Application number
CH754964A
Other languages
English (en)
Inventor
Shen Tsung-Ying
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US296451A external-priority patent/US3201414A/en
Priority claimed from US314503A external-priority patent/US3242185A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH455775A publication Critical patent/CH455775A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH754964A 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten CH455775A (de)

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
US16461562A 1962-01-05 1962-01-05
US28693563 US3161654A (en) 1962-01-05 1963-06-11 alpha-(1-aroyl-3-indolyl) alkanoic acids
US296451A US3201414A (en) 1963-07-22 1963-07-22 New 1-heteroacyl-3-indolyl aliphatic acids
US31045463A 1963-09-20 1963-09-20
US31047763A 1963-09-20 1963-09-20
US314503A US3242185A (en) 1963-10-07 1963-10-07 Lower aliphatic acids, salts and derivatives thereof
US32386363A 1963-11-04 1963-11-04
US321328A US3275644A (en) 1962-01-05 1963-11-04 Certain 1-azolylindol-3-ylaliphatic acids
US321686A US3275645A (en) 1962-01-05 1963-11-06 N-(1-acyl-3-indolyl)-acids
US437338A US3338921A (en) 1962-01-05 1965-01-26 Thenoic and furoic acids
US442152A US3328423A (en) 1962-01-05 1965-03-23 alpha-(3-indolyl)-cyclopropyl lower aliphatic acids
US528020A US3316267A (en) 1962-01-05 1966-02-15 Indolyl acids

Publications (1)

Publication Number Publication Date
CH455775A true CH455775A (de) 1968-05-15

Family

ID=27583773

Family Applications (3)

Application Number Title Priority Date Filing Date
CH755164A CH446333A (de) 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolderivaten
CH755064A CH447169A (de) 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolen
CH754964A CH455775A (de) 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH755164A CH446333A (de) 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolderivaten
CH755064A CH447169A (de) 1962-01-05 1964-06-10 Verfahren zur Herstellung von Indolen

Country Status (14)

Country Link
US (6) US3161654A (de)
AT (1) AT290523B (de)
BE (3) BE649166A (de)
BR (4) BR6459897D0 (de)
CH (3) CH446333A (de)
CS (1) CS164201B2 (de)
DE (1) DE1470069A1 (de)
DK (2) DK117068B (de)
FI (1) FI44910C (de)
FR (6) FR1459744A (de)
GB (3) GB1063230A (de)
IL (3) IL21376A (de)
NL (3) NL6406405A (de)
SE (1) SE300985B (de)

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242186A (en) * 1960-07-13 1966-03-22 Polaroid Corp 2, 5-dihydroxytriptycyl compounds and processes for their syntheses
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
US3376316A (en) * 1962-12-28 1968-04-02 Merck & Co Inc Lower alkyl gamma keto acid 2-pyranyl esters
US3306822A (en) * 1963-05-20 1967-02-28 Merck & Co Inc Anti-inflammatory therapy with 3-indolinyl compounds
BE659364A (de) * 1964-02-05
US3450814A (en) * 1964-07-15 1969-06-17 Chemway Corp Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
US3271394A (en) * 1964-12-31 1966-09-06 Merck & Co Inc Alpha-indolyl-3-acetic acid esters
US3417096A (en) * 1965-07-01 1968-12-17 Bristol Myers Co Certain 5(1-benzoyl-3-indolylmethyl) tetrazoles
US3397211A (en) * 1966-09-09 1968-08-13 Merck & Co Inc Process for preparing 3-indolyl acetic acids
US3471514A (en) * 1966-11-14 1969-10-07 Merck & Co Inc Process for alpha-(5-nitroindolyl-3)-alkanoic acids
US3468907A (en) * 1967-04-10 1969-09-23 Schering Corp Glyceryl esters of alpha-(1-aroyl-3-indolyl)alkanoic acids
NL6804994A (de) * 1967-04-11 1968-10-14
US3476770A (en) * 1967-04-14 1969-11-04 Parke Davis & Co 2-methyl-7-phenylindole-3-acetic acid compounds
US3501498A (en) * 1967-07-26 1970-03-17 Merck & Co Inc Nitro- and amino-substituted 1-p-chlorobenzyl-2-methyl-3-indolylacetic acids
US3497526A (en) * 1967-07-26 1970-02-24 Merck & Co Inc Organo-metallic compounds
HU162374B (de) * 1969-04-03 1973-02-28
US3800041A (en) * 1971-03-02 1974-03-26 Lilly Co Eli Analgesic compositions and methods
US3939178A (en) * 1971-06-01 1976-02-17 American Home Products Corporation Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
JPS49149723U (de) * 1973-04-25 1974-12-25
US4029798A (en) * 1975-06-02 1977-06-14 Sumitomo Chemical Company, Limited Analgetic composition
US4119638A (en) * 1976-11-29 1978-10-10 G. D. Searle & Co. Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
DK244179A (da) * 1978-06-13 1979-12-14 Merck & Co Inc Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
US4258185A (en) * 1978-10-17 1981-03-24 Yoshitomi Pharmaceutical Industries, Ltd. Pyridazinone compounds
DE2935776A1 (de) * 1979-09-05 1981-04-16 Theodor Prof. Dr. 4400 Münster Eckert Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
DE2943125A1 (de) * 1979-10-25 1981-05-14 Troponwerke GmbH & Co KG, 5000 Köln Verfahren zur herstellung von 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indol acetoxyessigsaeure
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
US4379792A (en) * 1980-10-30 1983-04-12 Merck & Co., Inc. Anti-inflammatory composition
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
LU83138A1 (de) * 1981-02-16 1981-09-11 T Eckert Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
DE3206885A1 (de) * 1982-02-26 1983-09-15 Troponwerke GmbH & Co KG, 5000 Köln Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4407804A (en) * 1982-06-30 1983-10-04 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and indomethacin
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
DE3431689A1 (de) * 1984-08-29 1986-03-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 5-acylpyrimidinen
JPS61152656A (ja) * 1984-12-27 1986-07-11 Taiho Yakuhin Kogyo Kk ピペラジン誘導体
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
EP0510080A4 (en) * 1989-12-26 1992-12-02 Nova Pharmaceutical Corporation Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
AU658373B2 (en) * 1990-11-06 1995-04-13 Fgn, Inc. Esters and amides of substituted pyrrole acetic acids
JP2552950B2 (ja) * 1990-11-13 1996-11-13 信越化学工業株式会社 アルコキシシランの製造方法
US5401774A (en) * 1991-03-08 1995-03-28 University Of Arizona Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds
AU650720B2 (en) * 1991-03-08 1994-06-30 Fgn, Inc. Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propionic acids and esters thereof
US5143927A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 3-(thiazolidone, oxazolidinone, imidazolidinone)-indoles as antiinflammatory agents
US5250552A (en) * 1991-05-09 1993-10-05 Warner-Lambert Company 3-[thiazolidinone, oxazolidinone, imidazolidinone]-indoles as antiinflammatory agents
US5124347A (en) * 1991-07-31 1992-06-23 Warner-Lambert Co. 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5436265A (en) * 1993-11-12 1995-07-25 Merck Frosst Canada, Inc. 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
US5776962A (en) * 1994-08-03 1998-07-07 Cell Pathways, Inc. Lactone compounds for treating patient with precancerous lesions
US5696159A (en) * 1994-08-03 1997-12-09 Cell Pathways, Inc. Lactone compounds for treating patients with precancerous lesions
US5484940A (en) * 1994-11-28 1996-01-16 Grant; Francine S. Substituted 3-indolyl-5-pyrazolone compounds
US5532237A (en) * 1995-02-15 1996-07-02 Merck Frosst Canada, Inc. Indole derivatives with affinity for the cannabinoid receptor
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
US5639780A (en) * 1995-05-22 1997-06-17 Merck Frosst Canada, Inc. N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
US6232312B1 (en) 1995-06-07 2001-05-15 Cell Pathways, Inc. Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
US5874440A (en) * 1995-06-07 1999-02-23 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
US6046216A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
US6200980B1 (en) 1995-06-07 2001-03-13 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl purinone derivatives
US6046206A (en) * 1995-06-07 2000-04-04 Cell Pathways, Inc. Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
US6262059B1 (en) 1995-06-07 2001-07-17 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with quinazoline derivatives
US5965619A (en) * 1996-06-13 1999-10-12 Cell Pathways Inc. Method for treating patients having precancerous lesions with substituted indene derivatives
US5998477A (en) * 1996-06-13 1999-12-07 Cell Pathways Inc. Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
US6063818A (en) * 1996-06-13 2000-05-16 Cell Pathways Inc. Substituted benzylidene indenyl formamides, acetamides and propionamides
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
CA2238283C (en) * 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
KR20010021625A (ko) 1997-07-09 2001-03-15 추후보정 개선된 남성발기 기능장애 치료방법 및 그 조성물
US5948779A (en) * 1997-12-12 1999-09-07 Cell Pathways, Inc. Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes
US5852035A (en) * 1997-12-12 1998-12-22 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
US6410584B1 (en) * 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6046199A (en) * 1998-01-14 2000-04-04 Cell Pathways, Inc. Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
US5942520A (en) * 1998-01-27 1999-08-24 Cell Pathways, Inc. Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines
US6028116A (en) * 1998-04-03 2000-02-22 Cell Pathways, Inc. Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
US5990117A (en) * 1998-04-15 1999-11-23 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6762182B1 (en) 1999-01-07 2004-07-13 Vanderbilt University Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
US6207700B1 (en) 1999-01-07 2001-03-27 Vanderbilt University Amide derivatives for antiangiogenic and/or antitumorigenic use
US6025394A (en) 1999-01-29 2000-02-15 Cell Pathways, Inc. Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
DE10006139A1 (de) * 2000-02-11 2001-08-16 Merck Patent Gmbh Indol-3-yl-Derivate
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
MXPA02008801A (es) * 2000-03-09 2003-07-07 Ono Pharmaceutical Co Derivados de indol, proceso para la preparacion de los mismos y su uso.
ES2215901T3 (es) 2000-04-27 2004-10-16 Basilea Pharmaceutica Ag Derivados de pirimidinil-metil-indol, con actividad antibacteriana.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
IT1318673B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Farmaci per le disfunzioni sessuali.
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
MXPA03007888A (es) * 2001-03-08 2003-12-04 Astrazeneca Ab Compuestos para tratamiento y prevencion de ulcera gastrica inducida por medicamentos.
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
KR20040044856A (ko) * 2001-09-07 2004-05-31 오노 야꾸힝 고교 가부시키가이샤 인돌 유도체 화합물
ITMI20020773A1 (it) * 2002-04-11 2003-10-13 Nicox Sa Farmaci per il trattamento dell'artrite
AU2004226479A1 (en) * 2003-03-27 2004-10-14 Evotec Oai Ophthalmic compositions for treating ocular hypertension
WO2005002293A2 (en) * 2003-06-25 2005-01-06 Vanderbilt University Cox-2-targeted imaging agents
JP2007527397A (ja) * 2003-07-01 2007-09-27 マイクロバイア インコーポレイテッド Ｃｏｘ−２及びｆａａｈ阻害剤
ITRM20030394A1 (it) 2003-08-12 2005-02-13 Maria Gabriella Santoro Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
US7491744B2 (en) * 2004-04-26 2009-02-17 Vanderbilt University Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
CA2583828A1 (en) * 2004-10-12 2006-04-27 Decode Genetics, Inc. Carboxylic acid peri-substituted bicyclics for occlusive artery disease
MX2007008156A (es) * 2005-01-04 2007-07-24 Novartis Ag Estructura de rayos-x de la fpps humana, y uso para seleccionar compuestos que se enlazan a fpps.
NZ569430A (en) * 2006-01-04 2012-05-25 Southern Res Inst Derivatives of sulindac, use thereof and preparation thereof
PT2026651E (pt) 2006-03-08 2013-06-04 Cortria Corp Terapia combinada com inibidores cox não selectivos para prevenir lesões gástricas relacionadas com a cox
US7736624B2 (en) * 2006-06-19 2010-06-15 Univ Vanderbilt Methods and compositions for diagnostic and therapeutic targeting of COX-2
JP5201660B2 (ja) * 2007-12-27 2013-06-05 独立行政法人産業技術総合研究所 ４−トリフルオロメチルインドール−３−酢酸
CN102924352B (zh) * 2011-08-10 2013-11-20 北京英力科技发展有限公司 一种合成4-巯基苯甲酸酯的方法
EP3078374B1 (de) 2011-10-17 2019-06-19 Vanderbilt University Indomethacin-analoga zur behandlung von kastrationsresistentem prostatakrebs
CN102827030B (zh) * 2012-09-24 2014-05-07 复旦大学 一种 (3r, 5r)-3, 5-二羟基-6-氰基己酸酯的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH307633A (de) * 1952-07-23 1955-06-15 Ciba Geigy Verfahren zur Herstellung eines Anthrachinonküpenfarbstoffes.

Also Published As

Publication number Publication date
GB1069775A (en) 1967-05-24
DK130922C (de) 1975-10-13
US3161654A (en) 1964-12-15
AT290523B (de) 1971-06-11
FR1426907A (fr) 1966-02-04
IL21431A (en) 1968-03-28
BE649166A (de) 1964-12-11
FI44910B (de) 1971-11-01
IL21376A (en) 1968-03-28
BR6914739D0 (pt) 1973-04-19
DE1470069A1 (de) 1969-05-14
CS164201B2 (de) 1975-11-07
GB1063230A (en) 1967-03-30
DK130922B (da) 1975-05-05
FR4065M (de) 1966-04-04
GB1063247A (en) 1967-03-30
US3316267A (en) 1967-04-25
IL21454A (en) 1968-05-30
FR1459744A (fr) 1966-06-17
US3338921A (en) 1967-08-29
FI44910C (fi) 1972-02-10
NL6406640A (de) 1964-12-14
NL6406406A (de) 1964-12-14
US3328423A (en) 1967-06-27
BR6459897D0 (pt) 1973-09-11
BR6459899D0 (pt) 1973-09-11
FR3933M (de) 1966-02-21
BR6459900D0 (pt) 1973-09-11
US3275645A (en) 1966-09-27
DK117068B (da) 1970-03-16
BE649169A (de) 1964-12-11
FR4114M (de) 1964-04-25
SE300985B (de) 1968-05-20
BE649167A (de) 1964-12-11
CH446333A (de) 1967-11-15
FR1452607A (fr) 1966-04-15
CH447169A (de) 1967-11-30
US3275644A (en) 1966-09-27
NL6406405A (de) 1964-12-14

Similar Documents

Publication Publication Date Title
CH455775A (de) Verfahren zur Herstellung von Indolyl-essigsäure-Derivaten
CH460779A (de) Verfahren zur Herstellung von Indolyl-Säure-Amiden
CH450416A (de) Verfahren zur Herstellung von halogenierten Indolylessigsäurederivaten
CH408006A (de) Verfahren zur Herstellung von Chinolyl-(8)-oxyessigsäurederivaten
CH461513A (de) Verfahren zur Herstellung von Pyrazolderivaten
CH485703A (de) Verfahren zur Herstellung von Pyromekonsäurederivaten
CH470385A (de) Verfahren zur Herstellung von Indolylsäuren
CH445514A (de) Verfahren zur Herstellung von 6-Alkylmorphinan-Derivaten
AT243234B (de) Verfahren zur Herstellung von Lösungen von Peroxydikohlensäureestern
AT249860B (de) Verfahren zur Herstellung von α-Aminoacyl-6-aminopenicillansäurederivaten
CH439296A (de) Verfahren zur Herstellung von Phenothiazinderivaten
CH438350A (de) Verfahren zur Herstellung von 6-Hydroxy-morphinan-Derivaten
CH469023A (de) Verfahren zur Herstellung von Derivaten der 7-Aminocephalosporansäure
AT244328B (de) Verfahren zur Herstellung von Sulfamylanthranilsäuren
CH451157A (de) Verfahren zur Herstellung von 7-Amino-cephalosporansäure
CH438355A (de) Verfahren zur Herstellung von Aminosäure-Derivaten
CH481897A (de) Verfahren zur Herstellung von substituierten Essigsäure-Derivaten
CH435270A (de) Verfahren zur Herstellung zinnhaltiger Derivate von Sulfosalicylsäuren
AT243986B (de) Verfahren zur Herstellung von 6-Acylaminopenicillansäuren
CH442349A (de) Verfahren zur Herstellung von Derivaten der a-Tetronsäure
CH424760A (de) Verfahren zur Herstellung von Derivaten der Fluor-dichlor-methansulfensäure
CH433271A (de) Verfahren zur Herstellung von bicyclischen Carbonsäurederivaten
CH429739A (de) Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten
CH478745A (de) Verfahren zur Herstellung von Aryloxyessigsäurederivaten
CH426778A (de) Verfahren zur Herstellung von N-Aryl-N-trifluormethylsulfen-säurehalogeniden